Intermolecular Inc (IMI) 0.99 $IMI Intermolecular to

New Post Public Reply Private Reply Replies (0) Message Board

Sep 27, 2016 at 11:04 AM

Intermolecular Inc (IMI) 0.99 $IMI

Intermolecular to Present at 2016 Flash Memory Summit on How High-Throughput Experimentation Can Identify the Most Promising Memory Selectors For 3D Cross-Point Non Volatile Memories
PR Newswire - Tue Aug 09, 11:11AM CDT
Intermolecular, Inc. (NASDAQ: IMI), the trusted partner in materials innovation, today announced it will present at the Flash Memory Summit on Thursday, August 11, 2016, at 8.30 am during the session 301-C: Intel-Micron 3D XpointTM: The Next Generation Non-Volatile Memory (New Technologies Track).
IMI: 0.99 (unch)

Intermolecular Announces Second Quarter 2016 Financial Results
PR Newswire - Thu Aug 04, 3:15PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its second quarter of fiscal 2016 ended June 30, 2016.
IMI: 0.99 (unch)

Intermolecular Appoints Chris Kramer President and CEO
PR Newswire - Thu Aug 04, 3:05PM CDT
Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced that Chris Kramer has been appointed as President and Chief Executive Officer reporting to Bruce McWilliams, who will assume the role of Executive Chairman.
IMI: 0.99 (unch)

Intermolecular Announces First Quarter 2016 Financial Results
PR Newswire - Thu May 05, 3:25PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its first quarter of fiscal 2016 ended March 31, 2016.
IMI: 0.99 (unch)

ReRAM Technology Now Available Through Intermolecular's New "IMI Discoveries" Licensed Products Business
PR Newswire - Thu May 05, 8:20AM CDT
Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced that its ReRAM technology is now available for licensing, marking the launch of the company's new IMI Discoveries licensed products business.
IMI: 0.99 (unch)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Intermolecular, Inc. - IMI
ACCESSWIRE - Wed Apr 20, 10:36AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / Levi & Korsinsky announces it has commenced an investigation of Intermolecular, Inc. (NASDAQGS: IMI) concerning possible breaches of fiduciary duty by its Board of Directors. To obtain additional information, GO TO: http://zlk.9nl.com/intermolecular-imi or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
IMI: 0.99 (unch)

Purcell Julie & Lefkowitz LLP Is Investigating Intermolecular, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed Apr 20, 8:41AM CDT
Shareholder rights law firm Purcell Julie & Lefkowitz LLP has commenced an investigation of Intermolecular, Inc. (NASDAQ: IMI) concerning possible breaches of fiduciary duty by its board of directors.
IMI: 0.99 (unch)

Intermolecular reports 4Q loss
Automated Insights - Thu Feb 04, 5:13PM CST
SAN JOSE, Calif. (AP) _ Intermolecular Inc. (IMI) on Thursday reported a loss of $1.9 million in its fourth quarter.
IMI: 0.99 (unch)

Intermolecular Reports Fourth Quarter 2015 and Full Year 2015 Financial Results
PR Newswire - Thu Feb 04, 3:16PM CST
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its fourth quarter and full year ended December 31, 2015.
IMI: 0.99 (unch)

Intermolecular to Report Fourth Quarter and Fiscal 2015 Financial Results on February 4, 2016
BusinessWire - Thu Jan 21, 3:15PM CST
Intermolecular, Inc. (NASDAQ: IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fourth quarter and fiscal year ended December 31, 2015 after the U.S. financial markets close on Thursday, February 4, 2016. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 0.99 (unch)

Intermolecular (IMI) Jumps: Stock Adds 8% in Session
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 7:40AM CST
Intermolecular, Inc. (IMI) saw its shares rise almost 8% in the last trading session.
FN: 43.72 (+0.14), IMI: 0.99 (unch)

Intermolecular Announces New Developments in its Relationship With Micron
BusinessWire - Mon Nov 23, 4:33PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced that its Collaborative Development Program ("CDP"

agreement with Micron Technology, Inc. ("Micron"

will conclude on April 1, 2016. "Micron is a valued customer that Intermolecular hopes to serve well into the future, but the CDP model has proven too restrictive for both companies," stated Bruce McWilliams, President and CEO of Intermolecular. "Under the terms of the agreement, next April is the first opportunity for the companies to end the CDP, and last week we received Micron's notice of termination effective April 1, 2016. Until then, the companies will continue to work together under the terms of the CDP agreement, and we will seek to transition Micron's DRAM work to our new business model."
IMI: 0.99 (unch)

Intermolecular Announces Third Quarter 2015 Results
BusinessWire - Thu Nov 05, 3:15PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced results for its third quarter ended September 30, 2015
IMI: 0.99 (unch)

Intermolecular to Report Third Quarter 2015 Financial Results on November 5, 2015
BusinessWire - Thu Oct 15, 3:10PM CDT
Intermolecular, Inc. (NASDAQ:IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fiscal third quarter ended September 30, 2015 after the U.S. financial markets close on Thursday, November 5, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 0.99 (unch)

Intermolecular (IMI) Catches Eye: Stock Moves 6.4% Higher
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 7:20AM CDT
Intermolecular, Inc. (IMI) was a big mover last session, as the company saw its shares rise more than 6% on the day.
NJ: 18.11 (-0.26), IMI: 0.99 (unch)

Intermolecular Announces Second Quarter 2015 Results
BusinessWire - Thu Aug 06, 3:18PM CDT
Intermolecular, Inc. (NASDAQ:IMI) - accelerating research and development (R&D) for advanced materials - today announced results for its second quarter ended June 30, 2015.
IMI: 0.99 (unch)

Intermolecular to Report Second Quarter 2015 Financial Results on August 6, 2015
BusinessWire - Thu Jul 16, 3:15PM CDT
Intermolecular, Inc. (NASDAQ:IMI)--accelerating research and development for semiconductor and clean energy industries--today announced it will release financial results for the fiscal second quarter ended June 30, 2015 after the U.S. financial markets close on Thursday, August 6, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 0.99 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...